Literature DB >> 1704202

Laboratory investigation of cerebrospinal fluid proteins.

E J Thompson1, G Keir.   

Abstract

Analysis of CSF proteins is useful in the diagnosis and management of neurological diseases in the following situations: 1. In inflammatory conditions when there is breakdown of blood-CSF barrier integrity. Meningitis is a medical emergency, with CSF total protein measurement being only a screening test. 2. In the detection of immune responses within the CNS. This is by far the most important application in a routine clinical setting, as it is now a firmly established criterion in the diagnosis of multiple sclerosis. Oligoclonal bands restricted to the CSF are the only reliable indicators of intrathecal immunoglobulin G synthesis and are practically always associated with inflammatory disease of the CNS. The method fo choice for detecting oligoclonal bands is isoelectric focusing with immunofixation. Quantitative measurement of IgG in the CSF is of no value in diagnostic pathology. 3. In destructive brain diseases when brain-specific proteins are released into the CSF, measurement of these proteins can give prognostic information.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1704202     DOI: 10.1177/000456329002700503

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  13 in total

1.  Diagnostic strategy used to establish etiologies of encephalitis in a prospective cohort of patients in England.

Authors:  H E Ambrose; J Granerod; J P Clewley; N W S Davies; G Keir; R Cunningham; M Zuckerman; K J Mutton; K N Ward; S Ijaz; N S Crowcroft; D W G Brown
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

2.  Cerebrospinal fluid analysis in clinical diagnosis.

Authors:  A O Olukoga; J Bolodeoku; D Donaldson
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

3.  Detection of meningeal fibrosis after subarachnoid haemorrhage by assaying procollagen propeptides in cerebrospinal fluid.

Authors:  J Sajanti; K Majamaa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

4.  Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression.

Authors:  Xiyun Chai; Su Wu; Tracey K Murray; Robert Kinley; Claire V Cella; Helen Sims; Nicola Buckner; Jenna Hanmer; Peter Davies; Michael J O'Neill; Michael L Hutton; Martin Citron
Journal:  J Biol Chem       Date:  2011-08-12       Impact factor: 5.157

5.  The Sexual Dimorphism in Cerebrospinal Fluid Protein Content Does Not Affect Intrathecal IgG Synthesis in Multiple Sclerosis.

Authors:  Massimiliano Castellazzi; Caterina Ferri; Ginevra Tecilla; André Huss; Paola Crociani; Gaetano Desina; Gianvito Barbella; Alice Piola; Samantha Permunian; Makbule Senel; Maurizio Leone; Hayrettin Tumani; Maura Pugliatti
Journal:  J Pers Med       Date:  2022-06-16

Review 6.  Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors.

Authors:  Nardin Samuel; Marc Remke; James T Rutka; Brian Raught; David Malkin
Journal:  J Neurooncol       Date:  2014-04-26       Impact factor: 4.130

Review 7.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Authors:  Samir Mitragotri; Paul A Burke; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-08-08       Impact factor: 84.694

8.  Aimless mutants of Cryptococcus neoformans: failure to disseminate.

Authors:  E J Griffiths; M Kretschmer; J W Kronstad
Journal:  Fungal Biol Rev       Date:  2012-03-30       Impact factor: 4.706

9.  Protein markers for the differential diagnosis of vascular dementia and Alzheimer's disease.

Authors:  A H Simonsen; N-O Hagnelius; G Waldemar; T K Nilsson; J McGuire
Journal:  Int J Proteomics       Date:  2012-06-04

10.  Sex-Related Differences in Cerebrospinal Fluid Plasma-Derived Proteins of Neurological Patients.

Authors:  Massimiliano Castellazzi; Caterina Ferri; Sarah Alfiero; Ilenia Lombardo; Michele Laudisi; Ginevra Tecilla; Michela Boni; Stefano Pizzicotti; Enrico Fainardi; Tiziana Bellini; Maura Pugliatti
Journal:  Diagnostics (Basel)       Date:  2021-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.